MACROGENICS INC's ticker is MGNX and the CUSIP is 556099109. A total of 112 filers reported holding MACROGENICS INC in Q1 2017. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $614,000 | -81.5% | 208,300 | -44.7% | 0.28% | -73.1% |
Q1 2022 | $3,316,000 | -55.3% | 376,400 | -18.5% | 1.03% | -34.5% |
Q4 2021 | $7,415,000 | -23.4% | 462,000 | 0.0% | 1.57% | -12.9% |
Q3 2021 | $9,674,000 | -37.7% | 462,000 | -20.1% | 1.81% | -29.9% |
Q2 2021 | $15,529,000 | -26.8% | 578,150 | -13.2% | 2.58% | -17.3% |
Q1 2021 | $21,218,000 | +150.4% | 666,200 | +79.8% | 3.12% | +181.6% |
Q4 2020 | $8,472,000 | -36.2% | 370,600 | -29.7% | 1.11% | -57.4% |
Q3 2020 | $13,275,000 | -5.1% | 527,000 | +5.2% | 2.60% | -8.1% |
Q2 2020 | $13,988,000 | +469.1% | 501,000 | +18.6% | 2.82% | +333.9% |
Q1 2020 | $2,458,000 | +12.7% | 422,300 | +110.6% | 0.65% | +52.1% |
Q4 2019 | $2,181,000 | +14.5% | 200,500 | +33.7% | 0.43% | -39.8% |
Q4 2018 | $1,905,000 | -45.2% | 150,000 | -11.8% | 0.71% | -65.3% |
Q4 2016 | $3,475,000 | -19.9% | 170,000 | +17.2% | 2.05% | -9.8% |
Q3 2016 | $4,337,000 | +43.5% | 145,000 | +29.5% | 2.27% | +12.4% |
Q2 2016 | $3,023,000 | +178.9% | 112,000 | +220.0% | 2.02% | +345.7% |
Q4 2015 | $1,084,000 | -68.3% | 35,000 | -61.1% | 0.45% | -66.7% |
Q2 2015 | $3,417,000 | +117.8% | 90,000 | +80.0% | 1.36% | +86.8% |
Q1 2015 | $1,569,000 | +87.2% | 50,000 | +66.7% | 0.73% | +17.6% |
Q1 2014 | $838,000 | – | 30,000 | – | 0.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Boxer Capital, LLC | 2,115,000 | $37,034,000 | 8.81% |
INTERWEST VENTURE MANAGEMENT CO | 1,074,316 | $18,811,000 | 4.45% |
DAFNA Capital Management LLC | 119,200 | $2,087,000 | 1.49% |
BB BIOTECH AG | 2,350,112 | $41,150,000 | 1.26% |
TIGER MANAGEMENT L.L.C. | 239,667 | $4,197,000 | 0.82% |
Hood River Capital Management LLC | 576,193 | $10,089,000 | 0.70% |
Bellevue Group AG | 316,418 | $5,540,000 | 0.66% |
Rhenman & Partners Asset Management AB | 175,000 | $3,064,000 | 0.44% |
First Light Asset Management, LLC | 61,538 | $1,078,000 | 0.36% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 54,000 | $945,000 | 0.36% |